Bausch Health Companies Inc. (TSX: BHC)
Canada
· Delayed Price · Currency is CAD 11.17
-0.28 (-2.45%)
Nov 22, 2024, 4:00 PM EST
Bausch Health Companies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 9,372 | 8,663 | 8,025 | 8,328 | 7,924 | 8,489 | Upgrade
|
| Other Revenue | 102 | 94 | 99 | 106 | 103 | 112 | Upgrade
|
| Revenue | 9,474 | 8,757 | 8,124 | 8,434 | 8,027 | 8,601 | Upgrade
|
| Revenue Growth (YoY) | 10.91% | 7.79% | -3.68% | 5.07% | -6.67% | 2.64% | Upgrade
|
| Cost of Revenue | 2,760 | 2,559 | 2,364 | 2,394 | 2,249 | 2,350 | Upgrade
|
| Gross Profit | 6,714 | 6,198 | 5,760 | 6,040 | 5,778 | 6,251 | Upgrade
|
| Selling, General & Admin | 3,229 | 2,895 | 2,531 | 2,492 | 2,367 | 2,554 | Upgrade
|
| Research & Development | 605 | 604 | 529 | 465 | 452 | 471 | Upgrade
|
| Other Operating Expenses | - | 1 | 1 | - | 1 | -13 | Upgrade
|
| Operating Expenses | 4,934 | 4,577 | 4,276 | 4,332 | 4,465 | 4,909 | Upgrade
|
| Operating Income | 1,780 | 1,621 | 1,484 | 1,708 | 1,313 | 1,342 | Upgrade
|
| Interest Expense | -1,414 | -1,328 | -1,464 | -1,426 | -1,534 | -1,612 | Upgrade
|
| Interest & Investment Income | 31 | 26 | 14 | 7 | 13 | 12 | Upgrade
|
| Currency Exchange Gain (Loss) | -40 | -52 | -8 | 7 | -30 | 8 | Upgrade
|
| EBT Excluding Unusual Items | 357 | 267 | 26 | 296 | -238 | -250 | Upgrade
|
| Merger & Restructuring Charges | -56 | -95 | -68 | -73 | -23 | -44 | Upgrade
|
| Impairment of Goodwill | -91 | -493 | -824 | -469 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 9 | 3 | 5 | 2 | 1 | 31 | Upgrade
|
| Asset Writedown | -6 | -45 | -10 | -211 | -112 | -66 | Upgrade
|
| Legal Settlements | -215 | - | -9 | -356 | -422 | -1,401 | Upgrade
|
| Other Unusual Items | -27 | -80 | 752 | -205 | -107 | -62 | Upgrade
|
| Pretax Income | -49 | -390 | -129 | -1,024 | -934 | -1,837 | Upgrade
|
| Income Tax Expense | 168 | 221 | 83 | -87 | -375 | -54 | Upgrade
|
| Earnings From Continuing Operations | -217 | -611 | -212 | -937 | -559 | -1,783 | Upgrade
|
| Minority Interest in Earnings | 39 | 19 | -13 | -11 | -1 | -5 | Upgrade
|
| Net Income | -178 | -592 | -225 | -948 | -560 | -1,788 | Upgrade
|
| Net Income to Common | -178 | -592 | -225 | -948 | -560 | -1,788 | Upgrade
|
| Shares Outstanding (Basic) | 367 | 365 | 362 | 359 | 355 | 352 | Upgrade
|
| Shares Outstanding (Diluted) | 367 | 365 | 362 | 359 | 355 | 352 | Upgrade
|
| Shares Change (YoY) | 0.90% | 0.80% | 0.86% | 1.10% | 0.82% | 0.23% | Upgrade
|
| EPS (Basic) | -0.48 | -1.62 | -0.62 | -2.64 | -1.58 | -5.08 | Upgrade
|
| EPS (Diluted) | -0.48 | -1.62 | -0.62 | -2.64 | -1.58 | -5.08 | Upgrade
|
| Free Cash Flow | 1,057 | 817 | -946 | 1,157 | 809 | 1,231 | Upgrade
|
| Free Cash Flow Per Share | 2.88 | 2.24 | -2.61 | 3.22 | 2.28 | 3.50 | Upgrade
|
| Gross Margin | 70.87% | 70.78% | 70.90% | 71.61% | 71.98% | 72.68% | Upgrade
|
| Operating Margin | 18.79% | 18.51% | 18.27% | 20.25% | 16.36% | 15.60% | Upgrade
|
| Profit Margin | -1.88% | -6.76% | -2.77% | -11.24% | -6.98% | -20.79% | Upgrade
|
| Free Cash Flow Margin | 11.16% | 9.33% | -11.64% | 13.72% | 10.08% | 14.31% | Upgrade
|
| EBITDA | 3,069 | 2,885 | 2,878 | 3,260 | 3,138 | 3,417 | Upgrade
|
| EBITDA Margin | 32.39% | 32.95% | 35.43% | 38.65% | 39.09% | 39.73% | Upgrade
|
| D&A For EBITDA | 1,289 | 1,264 | 1,394 | 1,552 | 1,825 | 2,075 | Upgrade
|
| EBIT | 1,780 | 1,621 | 1,484 | 1,708 | 1,313 | 1,342 | Upgrade
|
| EBIT Margin | 18.79% | 18.51% | 18.27% | 20.25% | 16.36% | 15.60% | Upgrade
|
| Revenue as Reported | 9,474 | 8,757 | 8,124 | 8,434 | 8,027 | 8,601 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.